41. RESULTS OF SINGLE-PORT VIDEO ASSISTED THORACOSOPIC LOBECTOMY IN THE TREATMENT OF EARLY STAGE NON-SMALL CELL LUNG CANCER AT NATIONAL LUNG HOSPITAL
Main Article Content
Abstract
Background: Lung cancer is the leading cause of cancer death in Vietnam. Total endoscopic lobectomy is indicated for the treatment of suitable stage non-small cell lung cancer. At National Lung Hospital Uniport VATS thoracoscopic lobectomy has been routinely perform to treat early stage non small cell lung cancer. We conducted a study on patients undergoing laparoscopic lobectomy at National Lung Hospital to evaluate the feasibility and safety of the surgery.
Methods: We conducted a study from January 2022 to December 2022 on 84 patients undergoing endoscopic lobectomy for non-small cell lung cancer at the National Lung Hospital.
Results: Most of the patients were in early stage, there were 8 patients with stage IIIA, the average operating time was 180 minutes, the average hospital stay was 8,8 days. There was 01 case of bleeding and 1 case of prolonged air leakage after surgery.
Conclusion: Uniport VATS thoracoscopic lobectomy at National Lung Hospital hospital shows feasibility and safety although there are still many problems to improve to improve the quality of treatment.
Article Details
Keywords
Lung cancer, uniport , VATS thoracoscopic surgery, lobectomy.
References
Global Cancer Statistics 2020: GLOBOCAN
Estimates of Incidence and Mortality Worldwide for
36 Cancers in 185 Countries. ACS J.2021;71(3):209–49.
[2] Brunelli, A. Charloux, C.T. Bolliger. ERS/ESTS
clinical guidelines on fitness for radical therapy
in lung cancer patients (surgery and chemo-radiotherapy).
Eur Respir J. 2009;34:17–41.
[3] Craig SR, Leaver HA, yap PL. Acute phase responses
following minimal access and conventional thoracic
surgery. Eur J Cardiothorac Surg.2001;20:455–63.
[4] Akinori Iwasaki, Results of videoassisted thoracic
surgery for stage I/II non-small cell lung
cancer. Eur J Cardiothorac Surg. 2004;26:158–64.
[5] Omar Lababede, Moulay A. Meziane. The
Eighth Edition of TNM Staging of Lung Cancer:
Reference Chart and Diagrams. Oncologist.
2018;23(7):844–8.
[6] Bộ Y tế, Chẩn đoán và điều trị ung thư phổi
không tế bào nhỏ. Quy Trình Hướng Dẫn Điều
Trị Các Bệnh Ung Thư, 2018.
[7] Phạm Hữu Lư, Nguyễn Mạnh Hiệp, Cắt thuỳ
phổi kèm nạo vét hạch điều trị ung thư phổi
không tế bào nhỏ giai đoạn sớm bằng phẫu thuật
nội soi lồng ngực một lỗ. Tạp Chí Học Việt Nam.
2022;513(2):291–4.
[8] Trần Minh Bảo Luân, Nguyễn Hoài Nam,
Đánh giá kết quả phẫu thuật cắt thùy phổi qua
nội soi lồng ngực trong điều trị ung thư phổi.
Phẫu Thuật Tim Mạch Và Lồng Ngực Việt Nam.
2018;23:97–103.
[9] Thân Trọng Vũ, Đánh giá kết quả phẫu thuật cắt
thùy phổi nội soi điều trị ung thư phổi không
phải tế bào nhỏ tại bệnh viện Đà Nẵng. Phẫu
Thuật Tim Mạch Và Lồng Ngực Việt Nam.
2018;23:59–64.
[10] Dekel Shlomi, Gingy Ronen Balmor, Screening
for lung cancer: Time for large-scale screening
by chest computed tomography. Eur Respir J.
2014;44:217–38.
[11] Ana Casal-Mouriño, Alberto Ruano- Ravina,
María Lorenzo-González, Epidemiology
of stage III lung cancer: Frequency, diagnostic
characteristics, and survival. Transl Lung Cancer Res.
2021;10(1):506–18.
[12] David S Ettinger, Douglas E Wood, Dara L
Aisner, Non-Small Cell Lung Cancer, Version 3.2022,
NCCN Clinical Practice Guidelines in Oncology. J Natl
Compr Canc Netw.2022;20(5):497–530.
[13] Paul J. Grant, M. Todd Greene, Scott Flanders,.
Assessing the Caprini Score for Risk Assessment
of Venous Thromboembolism in Hospitalized
Medical Patients. Am J Med. 2016;129(5):528–35.
[14] Adam Lackey, Jessica S. Donington. Surgical
Management of Lung Cancer. Semin Interv Radiol.
2013;13(30):133–40